Metabolic-Fit / 100
Invyncible review
One of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Invyncible at a glance
- Semaglutide
- $192.50/mo
- Tirzepatide
- $210/mo
- Coverage
- Not publicly disclosed; confirmed during intake
- Brand-name
- Yes
How we scored Invyncible
Every factor comes from Invyncible's own published pricing, disclosures and oversight, and the six combine into the 45/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.invyncible.com/semaglutide-programs
$192.50 for semaglutide and $210 for tirzepatide — the sale figures, which are the ones shown by default and used at checkout, though they sit permanently beside higher reference prices. Invyncible discloses its corporate parent, street address and a LegitScript seal, which is more than most compounded-only sellers manage. No state list is published.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $192.5 | Standard Formula InjectionsListed at $192.50 against a $275.00 reference price. Add-on tiers (Glycine+B12, B12, an oral option) run $149–$262.50/mo; the FDA-approved brand Wegovy is also sold direct on the same site at $1,750/mo (vs. $2,500 list). |
| Compounded tirzepatide | $210 | Standard Formula InjectionsListed at $210.00 against a $300.00 reference price. Add-on tiers (Glycine+B12, B12, B3) run $180–$250/mo; the FDA-approved brand Zepbound is also sold direct at $1,540/mo (vs. $2,200 list). |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Invyncible's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Discloses its corporate parent and a physical address — real accountability, not just a trade name
- LegitScript-verified
- Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
- No long-term commitment; cancel anytime per its own FAQ
The caveats
- No state-availability list published — you find out if it reaches you during intake
- Every price is shown as a permanent 'sale' against a higher reference price, which reads like a discount but never actually changes
- Brand-name Wegovy/Zepbound pricing ($1,540–$1,750/mo) is still well above most insurance-backed options
- Nothing on the site addresses pregnancy, breastfeeding, or postpartum timing specifically
Invyncible for mothers: our verdict
One of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake. It runs about $192.5/month.
We weigh Invyncible the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Invyncible costs, in full
- Compounded semaglutide — Standard Formula Injections: $192.5/mo
- Compounded tirzepatide — Standard Formula Injections: $210/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
Invyncible says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Invyncible prescribes
Invyncible prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
Where Invyncible fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Invyncible is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants the option to start compounded and later move to an FDA-approved brand pen without switching providers, and who values knowing the company's actual name and address.
Alternatives to Invyncible
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Invyncible
Head-to-head & alternatives
Invyncible, answered
- How much does Invyncible cost?
- At last review, Invyncible's lowest ongoing compounded rate was about $192.5 a month — $192.50/mo for semaglutide, $210/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Invyncible safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Invyncible is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Invyncible rank for mothers?
- Invyncible scores 45/100 on our Metabolic-Fit Score and sits at #153. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Invyncible's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.